NEPHROTOXICITY, OTOTOXICITY, NEUROMUSCULAR BLOCKADE and FETAL HARM
See full prescribing information for complete boxed warning
- TRADE NAME: Zemdri (Achaogen Inc)
- INDICATIONS: treatment of patients 18 years of age or older with Complicated Urinary Tract Infections (cUTI) including Pyelonephritis.
- CLASS: Antibiotic, Antibiotic; aminoglycoside, Antimicrobial
- HALF-LIFE: 3.5 hours
- FDA APPROVAL DATE: 06/25/2018
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known - PREGNANCY: Aminoglycosides can cause fetal harm, however, there are no available data on the use of Plazomicin in pregnant women to inform a drug associated risk of adverse developmental outcomes.
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
